Topics
July/August 2018
Share:
By Robin D. Ross, MD, MPH, CPH
David S. Boyer, MD
Allen C. Ho, MD, and Robert L. Avery, MD
Perspectives on Treatment With OZURDEX (dexamethasone intravitreal implant) 0.7 mg
Sponsored by Allergan
Digital 3D Retina Surgery: Are We at the Precipice of a New Standard of Care?
Sponsored by Alcon
Treating Retinal Disorders: Updates for the Newer Retina Specialist
This CME activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.
Swept Source OCT & OCT Angiography
Sponsored by Topcon
Recent Supplements
Gaining Patients’ Buy-in With Geographic Atrophy Treatment: The Journey From Diagnosis to Long-term Adherence
Editorially Independent Content, Supported With Advertising From Astellas
View Insert
One to Watch: Hong-Uyen Hua, MD
Editorially independent supported by Abbvie and Regenxbio
Navigating Copays in Retina Care
View Supplement
Rising Stars in Retina: Fares Antaki, MDCM
Understanding Fast Progression in Geographic Atrophy
One to Watch: Jordan D. Deaner, MD
View More
Eyetube Retina Series
EYETUBE RETINA MEETING COVERAGE